NewcelX ( ($NCEL) ) has issued an announcement. On December 11, 2025, NewcelX Ltd. announced the publication of a patent application in China for ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Syracuse, N.Y. — Girls basketball squads from across Section III are gearing up for an intriguing campaign, and some ...
As Big Pharma braces for a massive revenue crash when patents on blockbuster drugs expire, an unexpected player is stepping ...
Marcellus vs. Westhill, Dec. 2 and Jan. 13: The defending state champions open their season with a game against Class A ...
Dr. Kevin J. Tracey, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research and 2025 fellow of the ...
At the center of the patent is SenoVax (TM), Immorta Bio's first-in-class senolytic immunotherapy, which has demonstrated potent reduction of lung, breast, brain, skin, and pancreatic cancers in ...
NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China
NewcelX Ltd. (Nasdaq: NCEL), a next-generation biotechnology company developing advanced cell-therapy and neuroscience-driven ...
Credibly in Southfield, an AI-powered lending company geared to small and medium-sized businesses (SMBs), has announced the ...
Tulane’s J. Quincy Brown named 2025 NAI fellow for pioneering cancer imaging tech, including MAGIC-SCAN system.
"Sticky Kick [s] features tumbled yellow accents on the tongue and heel, the iconic Denny’s logo embossed on the heel counter ...
The "Me Too" drugs market offers opportunities by leveraging patent expirations, validated targets, and incremental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback